ASeq Newsletter

Home
Archive
About
There were a few further points I thought were worth addressing on Ultima Genomics. Some of these come from Keith’s excellent blog post on Ultima, others from a pre-print re-analyzing some of Ultima’s public data. I highly recommend checking out both these sources.
Nava Whiteford
NewTop
So, unsurprisingly MGI have announced their intent to re-enter the US sequencing market. They appear to be timing the release of their instrument to…
Nava Whiteford
8
Ultima Genomics is out of Stealth mode and announcing $600M in funding. I wrote about Ultima last year and got most things right based on their IP. So…
Nava Whiteford
7
Pleno recently came out of Stealth and announced a $15M round for their seemingly PCR-like but not PCR platform. There’s almost no information available…
Nava Whiteford
3
After my post on Qitan there were a few comments on twitter that I thought might be worth addressing. The first suggested that “this is not an ASIC…
Nava Whiteford
I’ve recently looked at 4 Chinese nanopore sequencing startups: AxBio, Genvida, RH Genetech, and Qitan Technology. In this post I’m going to briefly…
Nava Whiteford
2
The final, and potentially most interesting of the three Chinese nanopore startups I’ve recently been looking at is Qitan Technology. For a nanopore…
Nava Whiteford
3
While looking into Chinese nanopore companies I came across RH Genetech. The company appears to sell a number of instruments including air sampling LAMP…
Nava Whiteford
3
See all

ASeq Newsletter

AboutArchiveAuthorsSitemap
© 2022 Nava Whiteford
Privacy ∙ Terms ∙ Collection notice
Publish on Substack Get the app
Substack is the home for great writing